Search
5 results for www.astrazeneca.com:
ERROR: The request could not be satisfiedDatopotamab deruxtecan demonstrated statistically significant and clinically meaningful progression-free survival benefit in patients with HR-positive, HER2-low or negative breast cancer in TROPION-Breast01 Phase III trial - AstraZeneca
astrazeneca.comSubmitted by astrazenecacom1757 in business